Belgium· BE-AMP-SAM291681-00

Xyzall 0.5 mg/ml

A levocetirizine product containing levocetirizine dihydrochloride, registered in Belgium by UCB Pharma. The same ATC class is registered in 16 of our 19 countries.

ATC R06AE09

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedXyzall 0.5 mg/mlATCR06AE09REGISTER NO.BE-AMP-SAM291681-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Levocetirizine is registered in 16 of 19 countries.

Countries holding a registration under ATC R06AE09 (levocetirizine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Levocetirizine · ATC R06AE09

16 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levocetirizine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.15 in France to $0.53 in Switzerland — a ×3.4 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Levocetirizine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.53
  • ES Spain$0.34
  • IT Italy$0.21
  • FR France$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Levocetirizine Dihydrochloride
Manufacturer
UCB Pharma
Country
Belgium (BE)
ATC code
R06AE09
ATC class
Levocetirizine
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    2402915

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

267 interactions on record for levocetirizine.

Graded by severity as the source publishes them — 264 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levocetirizine · interactions on record

267 records

  • 264 moderate
  • 3 minor

Most severe, free to view

  • MetoclopramideA03FA01moderate
  • DimenhydrinatA04AB02moderate
  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levocetirizine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levocetirizine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Lecisyn, Lecivriens
  • Bulgaria · Алерцит, Зенаро
  • Cyprus · Ebrilon, Xyzal
  • Czechia · Alergimed, Analergin Neo
  • Germany · Levoceti Abz, Levocetirizin 1 A Pharma
  • Denmark · Levocetirizin Glenmark, Levocetirizin Krka
  • Estonia · Cezera, Lewojet
  • Spain · Aralevo, Levocetirizina Aurovitas Spain
  • Finland · Levocetirizin Ratiopharm, Levocetirizin Stada
  • France · Levocetirizine Arrow, Levocetirizine Biogaran
  • United Kingdom (Northern Ireland) · Levocetirizina Activase, Levocetirizine
  • Greece · Contrahist, Levocet
  • Croatia · Xyzal
  • Hungary · Cezera, Histisynt
  • Ireland · Levocetirizine Dihydrochloride Brillpharma (Ireland), Levocetirizine Glenmark
  • Italy · Levocetirizina Aurobindo, Levocetirizina Doc Generici
  • Lithuania · Cezera, Xyzal
  • Luxembourg · Levocetirizine Eg, Xyzall
  • Latvia · Xyzal
  • Malta · Rinozal, Xyzal
  • Netherlands · Cetirmar, Levocetirizine Dihcl Focus Care
  • Norway · Xyzal
  • Poland · Alergimed, Allefin Allergy
  • Portugal · Dicloridrato De Levocetirizina Ratiopharm, Levocetirizina
  • Romania · Cezera, Levocetirizină Terapia
  • Slovenia · Cezera, Xyzal
  • Slovakia · Alergimed, Cezera

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3f4c4fa7-b986-43e9-afb0-759d48bf1520
GET /v1/drugs/3f4c4fa7-b986-43e9-afb0-759d48bf1520?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Xyzall 0.5 mg/ml",
  "name_fr": "Xyzall 0.5 mg/ml",
  "name_nl": "Xyzall 0.5 mg/ml",
  "amp_code": "SAM291681-00",
  "strengths": [
    "0.5000",
    "235.2000",
    "400.0000",
    "0.6750",
    "0.0750",
    "0.5000",
    "3.4000"
  ],
  "pack_count": 3,
  "substances": [
    "Levocetirizine Dihydrochloride",
    "Glycerol",
    "Maltitol Liquid",
    "Methyl Parahydroxybenzoate",
    "Propyl Parahydroxybenzoate",
    "Saccharin Sodium",
    "Sodium Acetate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Levocetirizine",
  "authorisation_numbers": [
    "BE291681"
  ]
}

See everything about levocetirizine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.